Literature DB >> 18953154

Clinical research in India: great expectations?

U M Thatte1, S B Bavdekar.   

Abstract

India is considered as a preferred site for conducting global clinical trials. Existence of a large treatment-naïve population, availability of English-speaking, skilled doctors, plenty of clinical material, and cost-savings are obvious advantages for carrying out clinical research in India. However, challenges exist at various levels. Lack of formal training in bioethics and research methodology, heavy burden of clinical duties and sub-optimal administrative support restrict investigators. Absence of oversight of functioning of ethics committees (ECs) and lack of mechanisms for ensuring quality of ethics review heighten societal concerns about safety of participants. Conducting research on issues not relevant to local needs and failure to ensure post-trial access further enhance society's cynicism. These issues need to be tackled through capacity building, training of investigators and EC members, strengthening of EC functioning and encouraging greater community participation.

Entities:  

Mesh:

Year:  2008        PMID: 18953154     DOI: 10.4103/0022-3859.43517

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  13 in total

1.  Compliance of Mumbai-based clinical trial sites with the Quality Council of India guidelines and evaluation of the challenges faced by the investigators.

Authors:  Brinal Figer; Nithya Jaideep Gogtay; Urmila Mukund Thatte
Journal:  Perspect Clin Res       Date:  2021-01-15

2.  Ethics committees in India: Facing the challenges!

Authors:  Rashmi Kadam; Shashikant Karandikar
Journal:  Perspect Clin Res       Date:  2012-04

3.  Ophthalmic research and publication in India: where do we stand?

Authors:  Barun Kumar Nayak
Journal:  Indian J Ophthalmol       Date:  2010 Jul-Aug       Impact factor: 1.848

4.  The Year Ahead: An initiative to assess the impact of an intervention "Speaking Book" on awareness among the potential participants about clinical trials in India.

Authors:  Urmila Thatte; Santosh Taur
Journal:  Perspect Clin Res       Date:  2011-07

5.  Quality of independent review board/ethics committee oversight in clinical trials in India.

Authors:  Anvita Pandiya
Journal:  Perspect Clin Res       Date:  2011-04

Review 6.  Challenges in launching multinational oncology clinical trials in India.

Authors:  Kamal S Saini; Gaurav Agarwal; Ramesh Jagannathan; Otto Metzger-Filho; Monika L Saini; Khurshid Mistry; Raghib Ali; Sudeep Gupta
Journal:  South Asian J Cancer       Date:  2013-01

7.  An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India.

Authors:  Shruti S Bhide; Jahnavi V Katkar; Mitesh Maurya; Nithya Jaideep Gogtay; Urmila M Thatte
Journal:  Perspect Clin Res       Date:  2016 Oct-Dec

Review 8.  Ethics Committees in India: Past, present and future.

Authors:  Urmila M Thatte; Padmaja A Marathe
Journal:  Perspect Clin Res       Date:  2017 Jan-Mar

9.  Erratum: A cross-sectional study: Need of equal respect for all professionals in the Institutional Ethics Committees' composition.

Authors: 
Journal:  Perspect Clin Res       Date:  2017 Jul-Sep

10.  Clinical research regulation in India-history, development, initiatives, challenges and controversies: Still long way to go.

Authors:  Mohammed Imran; Abul K Najmi; Mohammad F Rashid; Shams Tabrez; Mushtaq A Shah
Journal:  J Pharm Bioallied Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.